Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 282 of 1,261
  1. US 11246933

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  2. US 11246859

    Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

    Biomed Valley Discoveries, Inc. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  3. US 11248039

    Immunoglobulin single variable domain antibody against RSV prefusion F protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  4. US 11246947

    Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

    Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  5. US 11246926

    Polynucleotides encoding anti-C1s antibodies

    Bioverativ USA Inc. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  6. US 11246940

    Peptides whose uptake in cells is controllable

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  7. US 11248056

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  8. US 11246871

    Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias

    Northwestern University · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  9. US 11248044

    Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  10. US 11248270

    Methods and kits to identify Klebsiella strains

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  11. US 11248213

    Platform for generating safe cell therapeutics

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  12. US 11248022

    Glypican-3 peptide reagents and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  13. US 11247969

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  14. US 11246950

    Combination cancer immunotherapy with pentaaza macrocyclic ring complex

    Galera Labs, LLC · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  15. US 11247971

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  16. US 11247968

    Lipocationic dendrimers and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  17. US 11246961

    Engineered scaffolds for vascularized tissue repair

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  18. US 11246930

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  19. US 11246937

    One-step processing of hydrogels for mechanically robust and chemically desired features

    The Board of Regents of the University of Texas System · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  20. US 11246881

    Nanoparticle to target cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  21. US 11246875

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  22. US 11247985

    Phenyl indole allosteric inhibitors of P97 ATPase

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  23. US 11246858

    Immunoresponsive methods of treating tumors

    INSTITUT PASTEUR DE MONTEVIDEO · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  24. US 11247974

    Small molecules that enable cartilage rejuvenation

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.